Cargando…

Functional analysis of the receptor binding domain of SARS coronavirus S1 region and its monoclonal antibody

Severe acute respiratory syndrome (SARS) is caused by the SARS coronavirus (CoV). The spike protein of SARS-CoV consists of S1 and S2 domains, which are responsible for virus binding and fusion, respectively. The receptor-binding domain (RBD) positioned in S1 can specifically bind to angiotensin-con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun, Hong, Yeongjin, Shibayama, Keigo, Suzuki, Yasuhiko, Wakamiya, Nobutaka, Kim, Youn Uck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Genetics Society of Korea 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097624/ http://dx.doi.org/10.1007/s13258-014-0186-9

Ejemplares similares

DNA gyrase could be a crucial regulatory factor for growth and survival of Mycobacterium leprae
por: Kim, Hyun, et al.
Publicado: (2019)

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
por: Tian, Xiaolong, et al.
Publicado: (2020)

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
por: Berry, Jody D, et al.
Publicado: (2004)

Establishment and Characterization of Monoclonal Antibodies Against SARS Coronavirus
por: Ohnishi, Kazuo
Publicado: (2007)

Characterization of Two Monoclonal Antibodies That Recognize Linker Region and Carboxyl Terminal Domain of Coronavirus Nucleocapsid Protein
por: Zhang, Xin, et al.
Publicado: (2016)

Biological Functions of the Novel Collectins CL-L1, CL-K1, and CL-P1
por: Ohtani, Katsuki, et al.
Publicado: (2012)

Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
por: Kim, Ji Woong, et al.
Publicado: (2022)

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
por: ter Meulen, Jan, et al.
Publicado: (2004)

Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies
por: Maghsood, Faezeh, et al.
Publicado: (2022)

Novel monoclonal antibodies targeting the microtubule-binding domain of human tau
por: Croft, Cara L., et al.
Publicado: (2018)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms
por: Coughlin, Melissa M., et al.
Publicado: (2009)

Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus
por: Shang, Bo, et al.
Publicado: (2005)

Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain †
por: Cruz, Victor L., et al.
Publicado: (2023)

Identification of conserved linear epitopes in the SARS-CoV-2 receptor-binding region using monoclonal antibodies
por: Yang, Yujie, et al.
Publicado: (2023)

Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus
por: Gubbins, Michael J., et al.
Publicado: (2005)

Monoclonal antibodies binding data for SARS-CoV-2 proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse(®)
por: Coughlin, Melissa, et al.
Publicado: (2007)

Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants
por: Neamtu, Andrei, et al.
Publicado: (2023)

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2
por: Corrêa Giron, Carolina, et al.
Publicado: (2020)

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
por: ter Meulen, Jan, et al.
Publicado: (2006)

The “SARS-unique domain” (SUD) of SARS coronavirus is an oligo(G)-binding protein
por: Tan, Jinzhi, et al.
Publicado: (2007)

Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody
por: Ng, Oi-Wing, et al.
Publicado: (2014)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies
por: Chan, Conrad En-Zuo, et al.
Publicado: (2022)

SARS Coronavirus Unique Domain: Three-Domain Molecular Architecture in Solution and RNA Binding
por: Johnson, Margaret A., et al.
Publicado: (2010)

The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene
por: Kim, Sinae, et al.
Publicado: (2020)

Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA
por: He, Qigai, et al.
Publicado: (2005)

Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
por: Ling, Zhiyang, et al.
Publicado: (2022)

Effects of a monoclonal antibody against (pro)renin receptor on gliomagenesis
por: Fujimori, Takeshi, et al.
Publicado: (2023)

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
por: Tripp, Ralph A., et al.
Publicado: (2005)

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020)

Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
por: Parray, Hilal Ahmad, et al.
Publicado: (2020)

Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody
por: Bian, Chao, et al.
Publicado: (2009)

Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain
por: Lai, Guan-Chun, et al.
Publicado: (2022)

Characterization of the C6D7-RBD Human Monoclonal Antibody Specific to the SARS-CoV-2 S Protein Receptor-Binding Domain
por: Romanenko, Ya. O., et al.
Publicado: (2023)

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
por: Xiang, Rong, et al.
Publicado: (2022)

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein
por: Goo, Junghyun, et al.
Publicado: (2020)

Antineutrophil cytoplasmic antibody–negative pauci-immune glomerulonephritis with massive intestinal bleeding
por: Kim, Miyeon, et al.
Publicado: (2015)

The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection
por: Zhang, Xuyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4jpk6ec6h0pftp9cgsegm7ce1k